Asymmetric dimethylarginine: Is it a risk facgtor in the repair of aortic coarctation?
Tolga BaşMurat KoçOnur IsikHakan HançerAli KutsalPublished in: Journal of cardiac surgery (2021)
Perioperative serum ADMA levels could be used as a prognostic bio-marker in the patients undergoing aortic coarctation repair. Treatments to reduce serum ADMA levels can be valuable for preventing mortality and morbidity which develop after surgeries in a transient ischemia setting by clamping the aorta.
Keyphrases
- patients undergoing
- aortic valve
- pulmonary artery
- aortic dissection
- left ventricular
- cardiac surgery
- coronary artery
- cardiovascular events
- heart failure
- pulmonary hypertension
- arterial hypertension
- pulmonary arterial hypertension
- risk factors
- cardiovascular disease
- coronary artery disease
- brain injury
- atrial fibrillation